Glycopyrrolate Injection
Product Images NDC 51662-1554

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1554 2 Pouch Labeling)

Label for Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) 2 mL vial. The label shows the NDC 51662-1554-2, lot number 12345, and expiration date 2025-01-01. It is manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label includes storage instructions and a QR code.*

FDA Label Image

Case Labeling (51662 1554 3 Case Labeling)

Label of GLYCOPYRROLATE Injection USP 0.4 mg/2 mL (0.2 mg/mL) vial from HF Acquisition Co LLC DBA HealthFirst. The label indicates a 2 mL vial in a box of 25, with an NDC code of 51662-1554-3 and an expiration date of January 1, 2025. Additional text includes lot number, storage instructions, and manufacturer information.*

FDA Label Image

Serialized Label (51662 1554 3 Serialized Labeling)

A small white label with black text and a data matrix barcode, showing serialization and distribution data. The label includes serialized numbers and states the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label is marked with 'RX ONLY' vertically on the right side, indicating prescription status. No proprietary or strength information is visible on the label in the image.*

FDA Label Image

Clinical (Clinical Pharmacology)

A data table presenting pharmacokinetic parameters for glycopyrrolate administered intravenously (6 mcg/kg IV) and intramuscularly (8 mcg/kg IM). The table includes values for half-life (t1/2), volume of distribution at steady state (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC). Some values are not reported for certain groups.*

FDA Label Image

Description (Description)

Chemical structure of glycopyrrolate showing its molecular arrangement with corresponding molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Vial Label (Vial Labeling)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial for intramuscular or intravenous use. The label indicates it contains benzyl alcohol and is distributed by West-Ward. Includes a barcode, NDC 0143-9681-01, and spaces for lot and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.